title: Survivin promotion of melanoma metastasis requires upregulation of α5 integrin.
abstract: Survivin is an apoptotic and mitotic regulator that is overexpressed in melanoma and a poor prognostic marker in patients with metastatic disease. We recently showed that Survivin enhances melanoma cell motility through Akt-dependent upregulation of α5 integrin. However, the functional role of Survivin in melanoma metastasis is not clearly understood. We found that overexpression of Survivin in LOX and YUSAC2 human melanoma cells increased colony formation in soft agar, and this effect was abrogated by knockdown of α5 integrin by RNA interference. We employed melanoma cell xenografts to determine the in vivo effect of Survivin overexpression on melanoma metastasis. Although Survivin overexpression did not affect primary tumor growth of YUSAC2 or LOX subcutaneous tumors, or indices of proliferation or apoptosis, it significantly increased expression of α5 integrin in the primary tumors and formation of metastatic colonies in the lungs. Additionally, Survivin overexpression resulted in enhanced lung colony formation following intravenous (i.v.) injection of tumor cells in vivo and increased adherence to fibronectin-coated plastic in vitro. Importantly, in vivo inhibition of α5 integrin via intraperitoneal injection of an α5β1 integrin-blocking antibody significantly slowed tumor growth and reduced Survivin-enhanced pulmonary metastasis. Knockdown of α5 integrin in cells prior to i.v. injection also blocked Survivin-enhanced lung colony formation. These findings support a direct role for Survivin in melanoma metastasis, which requires α5 integrin and suggest that inhibitors of α5 integrin may be useful in combating this process.
authors: Department of Oncological Sciences.
authors: Jodi A
authors: JA
authors: McKenzie
authors: Tong
authors: T
authors: Liu
authors: Jae Y
authors: JY
authors: Jung
authors: Benjamin B
authors: BB
authors: Jones
authors: Huseyin A
authors: HA
authors: Ekiz
authors: Alana L
authors: AL
authors: Welm
authors: Douglas
authors: D
authors: Grossman
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000235:genetics* / Q000378:metabolism; D039482:Integrin alpha5 / Q000235:genetics* / Q000378:metabolism; D008545:Melanoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D009362:Neoplasm Metastasis / Q000235:genetics* / Q000473:pathology; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D034622:RNA Interference; D000077022:Survivin; D015854:Up-Regulation
chemical_list: C107489:BIRC5 protein, human; D051034:Inhibitor of Apoptosis Proteins; D039482:Integrin alpha5; D000077022:Survivin; D051057:Proto-Oncogene Proteins c-akt
references: Blood. 1996 Jun 1;87(11):4718-22
references: 8639841
references: N Engl J Med. 2010 Aug 19;363(8):711-23
references: 20525992
references: J Cell Biochem. 2004 Jul 1;92(4):656-63
references: 15211564
references: Cancer Metastasis Rev. 2005 Jun;24(2):195-222
references: 15986132
references: Clin Cancer Res. 2009 Feb 15;15(4):1326-34
references: 19228734
references: Mol Cancer Ther. 2011 Feb;10(2):221-32
references: 21216939
references: N Engl J Med. 2006 Jul 6;355(1):51-65
references: 16822996
references: Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26
references: 15459662
references: Cell Stem Cell. 2008 Jan 10;2(1):90-102
references: 18371425
references: Oncogene. 2004 Jan 8;23(1):39-48
references: 14712209
references: Oncogene. 2011 Mar 31;30(13):1566-76
references: 21119598
references: J Surg Oncol. 2012 May;105(6):520-8
references: 22065492
references: Clin Cancer Res. 2008 Aug 15;14(16):5000-5
references: 18698017
references: J Clin Oncol. 2003 Jan 15;21(2):306-12
references: 12525523
references: J Cell Sci. 2002 Oct 1;115(Pt 19):3729-38
references: 12235283
references: Cancer Res. 2010 Oct 15;70(20):7927-37
references: 20807805
references: Cancer Lett. 2007 Mar 8;247(1):1-25
references: 16725254
references: Am J Respir Cell Mol Biol. 2010 Dec;43(6):684-91
references: 20081050
references: N Engl J Med. 2011 Jun 30;364(26):2507-16
references: 21639808
references: Oncogene. 2011 Jan 20;30(3):265-74
references: 20838381
references: Oncogene. 2008 Oct 20;27(48):6276-84
references: 18931693
references: Cancer Res. 2008 Apr 1;68(7):2329-39
references: 18381440
references: J Exp Ther Oncol. 2006;5(4):273-86
references: 17024968
references: Nat Rev Cancer. 2002 Feb;2(2):91-100
references: 12635172
references: Carcinogenesis. 2005 Mar;26(3):513-23
references: 15358632
references: BMC Med. 2012 Mar 02;10:23
references: 22385436
references: J Cell Sci. 2009 Nov 15;122(Pt 22):4009-11
references: 19910492
references: Mol Cancer Ther. 2006 Sep;5(9):2271-80
references: 16985061
references: Nat Rev Cancer. 2002 Aug;2(8):563-72
references: 12154349
references: J Invest Dermatol. 2011 Sep;131(9):1817-20
references: 21593776
references: Biochem Biophys Res Commun. 2005 Aug 12;333(4):1269-75
references: 15979576
references: Nat Med. 1997 Aug;3(8):917-21
references: 9256286
references: Oncogene. 2010 Feb 25;29(8):1227-37
references: 19946336
references: Int J Cancer. 2005 Dec 20;117(6):1032-8
references: 15986442